Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

MHC class II DQ Activators

The Major Histocompatibility Complex (MHC) class II DQ is an integral element of the immune system, playing a pivotal role in the body's defense mechanism. These molecules are primarily expressed on the surface of antigen-presenting cells, such as B cells, macrophages, and dendritic cells. Their main function is to present exogenous peptide antigens to helper T cells, facilitating the adaptive arm of the immune system. The MHC class II DQ proteins are highly polymorphic, which allows them to bind and present a wide array of antigens, ensuring a broad and effective immune response. The expression of these molecules is tightly controlled and can be upregulated in response to certain environmental cues, such as the presence of pathogens.

A variety of chemical compounds can serve as activators, stimulating the expression of MHC class II DQ proteins. These activators often initiate signaling pathways that lead to transcriptional activation of the genes encoding MHC class II DQ. For instance, compounds such as lipopolysaccharide (LPS), a component of bacterial cell walls, can trigger toll-like receptors, leading to a cascade that results in the heightened expression of MHC class II molecules. Similarly, synthetic compounds like CpG oligodeoxynucleotides, which mimic bacterial DNA, can also induce expression through interaction with intracellular toll-like receptor 9 (TLR9). Other chemicals, such as Vitamin D3 and retinoic acid, can also stimulate the expression of MHC class II DQ by binding to their respective receptors and activating specific nuclear transcription factors. These activators do not act in isolation; rather, they are part of a complex network of signals that finely tune the immune response by controlling the expression of MHC class II DQ proteins.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lipopolysaccharide, E. coli O55:B5

93572-42-0sc-221855
sc-221855A
sc-221855B
sc-221855C
10 mg
25 mg
100 mg
500 mg
$98.00
$171.00
$425.00
$1560.00
12
(2)

LPS triggers toll-like receptor 4 (TLR4) on immune cells, leading to a cascade that culminates in the upregulation of MHC class II DQ expression.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$71.00
$163.00
$296.00
2
(1)

As an immunomodulatory secosteroid, Cholecalciferol interacts with its receptor on immune cells, prompting the upsurge of MHC class II DQ molecules.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid engages with retinoic acid receptors, resulting in transcriptional changes that include the escalation of MHC class II DQ levels.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide engages cellular mechanisms that can lead to the enhanced transcription and subsequent expression of MHC class II DQ.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

PGE2 binds to its E-prostanoid receptors on various immune cells, which can lead to the increased expression of MHC class II DQ.

Azathioprine

446-86-6sc-210853D
sc-210853
sc-210853A
sc-210853B
sc-210853C
500 mg
1 g
2 g
5 g
10 g
$203.00
$176.00
$349.00
$505.00
$704.00
1
(1)

Azathioprine can lead to the oxidative stress response, which may include the increased expression of MHC class II DQ on antigen-presenting cells.

Budesonide

51333-22-3sc-202980
sc-202980A
sc-202980B
sc-202980C
50 mg
100 mg
200 mg
500 mg
$79.00
$90.00
$154.00
$350.00
3
(1)

Budesonide may exert a promoting effect on MHC class II DQ expression through its action on nuclear factor-kappa B (NF-κB) pathways.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate can stimulate the expression of MHC class II DQ by interfering with folate metabolism and subsequent immunological signaling.